EXPERT REVIEW OF CARDIOVASCULAR THERAPY, cilt.14, sa.9, ss.1053-1070, 2016 (ESCI)
Introduction: With new developments in percutaneous coronary intervention (PCI), such as the introduction of bioresorbable scaffolds (BRS), percutaneous treatment of coronary artery diseases has entered a new era. Without metallic remnants, BRSs appear able to overcome several limitations of the existing metallic stents and provide a physiologic treatment of coronary artery pathology.